Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Skelly

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Gene Therapy|March 16, 2012
Modulating vascular intimal hyperplasia using HSV-1 mutant requires activated MEKC L Skelly, Q He, L Spiguel, et al.
Annals of Vascular Surgery|February 28, 2001
The hemodynamics of vein grafts: measurement and meaningC L Skelly, S L Meyerson, M A Curi, et al.
Annals of Vascular Surgery|June 21, 2001
Adenoviral-mediated gene transfer in human and animal vein grafts using clinically relevant exposure times, pressures, and viral concentrationsJ Moawad, S L Meyerson, D Refai, et al.
Journal of Vascular Surgery|May 11, 2000
Effective hemodynamic diameter: an intrinsic property of vein grafts with predictive value for patencyS L Meyerson, J Moawad, F Loth, et al.
Journal of Vascular Surgery|July 4, 2001
The effects of extremely low shear stress on cellular proliferation and neointimal thickening in the failing bypass graftS L Meyerson, C L Skelly, M A Curi, et al.
Annals of Vascular Surgery|May 5, 2000
Estimating the contemporary in-hospital costs of carotid endarterectomyZ K Baldwin, S L Meyerson, C L Skelly, et al.
Journal of Vascular Surgery|July 4, 2001
Long-term results justify autogenous infrainguinal bypass grafting in patients with end-stage renal failureS L Meyerson, C L Skelly, M A Curi, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 26, 2001
Patency and limb salvage after infrainguinal bypass with severely compromised ("blind") outflowT R Desai, S L Meyerson, C L Skelly, et al.
Gene Therapy|February 1, 2002
Prevention of restenosis by a herpes simplex virus mutant capable of controlled long-term expression in vascular tissue in vivoC L Skelly, M A Curi, S L Meyerson, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Gene Therapy|March 16, 2012
Modulating vascular intimal hyperplasia using HSV-1 mutant requires activated MEKC L Skelly, Q He, L Spiguel, et al.
Annals of Vascular Surgery|February 28, 2001
The hemodynamics of vein grafts: measurement and meaningC L Skelly, S L Meyerson, M A Curi, et al.
Annals of Vascular Surgery|June 21, 2001
Adenoviral-mediated gene transfer in human and animal vein grafts using clinically relevant exposure times, pressures, and viral concentrationsJ Moawad, S L Meyerson, D Refai, et al.
Journal of Vascular Surgery|May 11, 2000
Effective hemodynamic diameter: an intrinsic property of vein grafts with predictive value for patencyS L Meyerson, J Moawad, F Loth, et al.
Journal of Vascular Surgery|July 4, 2001
The effects of extremely low shear stress on cellular proliferation and neointimal thickening in the failing bypass graftS L Meyerson, C L Skelly, M A Curi, et al.
Annals of Vascular Surgery|May 5, 2000
Estimating the contemporary in-hospital costs of carotid endarterectomyZ K Baldwin, S L Meyerson, C L Skelly, et al.
Journal of Vascular Surgery|July 4, 2001
Long-term results justify autogenous infrainguinal bypass grafting in patients with end-stage renal failureS L Meyerson, C L Skelly, M A Curi, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 26, 2001
Patency and limb salvage after infrainguinal bypass with severely compromised ("blind") outflowT R Desai, S L Meyerson, C L Skelly, et al.
Gene Therapy|February 1, 2002
Prevention of restenosis by a herpes simplex virus mutant capable of controlled long-term expression in vascular tissue in vivoC L Skelly, M A Curi, S L Meyerson, et al.
Pageof 1